Pharmabiz19m
New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients
New Novartis data in relapsing MS reinforce benefits of Kesimpta for first-line and switch patients: Basel Friday, September 20, 2024, 12:00 Hrs [IST] Novartis announced new data ...
Pharmabiz1h
Astellas Pharma announces US FDA listing of DIGITIVA for the management of heart failure
Astellas Pharma announces US FDA listing of DIGITIVA for the management of heart failure: Tokyo Friday, September 20, 2024, 11:00 Hrs [IST] Astellas Pharma Inc. announced that DIG ...
Pharmabiz2h
Takeda commits over US$ 32 million in five new global CSR partnerships to further drive health impact in 93 countries
Takeda commits over US$ 32 million in five new global CSR partnerships to further drive health impact in 93 countries: Osaka, Japan Friday, September 20, 2024, 10:00 Hrs [IST] Tak ...
Pharmabiz19h
SAKCON 2024 proves to be an event par excellence on patient centric care
In a landmark moment for the healthcare industry, the School of Business Management, NMIMS, Mumbai, in collaboration with ...
Pharmabiz4h
Karnataka DC dept launches online tracking system for sale of tapentadol as misuse reported
Karnataka DC dept launches online tracking system for sale of tapentadol as misuse reported: Nandita Vijaysimha, Bengaluru Friday, September 20, 2024, 08:00 Hrs [IST] The Karnatak ...
Pharmabiz3h
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses
Roche announces phase III CENTERSTONE study of Xofluza significantly reduces the transmission of influenza viruses: Basel Friday, September 20, 2024, 09:00 Hrs [IST] Roche announc ...
Pharmabiz4h
DCC recommends issuance of advisory to SLAs for monitoring quality of eye drops in packages
The Drugs Consultative Committee (DCC) has recommended to the national drug regulatory authority to issue an advisory to the State Licensing Authorities to monitor the quality of eye drops in packages ...
Pharmabiz4h
PvPI and ADR monitoring & reporting should be made part of pharmacy curriculum: Dr B Suresh
Peethaambaran Kunnathoor, Chennai Friday, September 20, 2024, 08:00 Hrs [IST] ...
Pharmabiz4h
Gujarat pharma leaders gather in Vapi to discuss Revised Schedule M guidelines
Gujarat pharma leaders gather in Vapi to discuss Revised Schedule M guidelines: Shardul Nautiyal, Mumbai Friday, September 20, 2024, 08:00 Hrs [IST] In a pivotal move towards impr ...
Pharmabiz4h
Government tightens limits on interest equalisation scheme for exporters, caps announced for 2024
The Directorate General of Foreign Trade (DGFT) has issued an important amendment to the Interest Equalisation Scheme (IES), providing updated guidelines for exporters. In a Trade Notice, the ...
Pharmabiz13h
Study shows use of metformin in adults with diabetes linked to lower risk of long Covid
Adults who use the prescription drug metformin to treat their type 2 diabetes have a lower risk of developing long Covid or dying after a Covid-19 infection than people with diabetes who take other ...
Pharmabiz20h
Oxymed introduces 'Try & Buy' scheme for CPAP machines to address rising sleep apnoea
Oxymed introduces 'Try & Buy' scheme for CPAP machines to address rising sleep apnoea: Our Bureau, Mumbai Thursday, September ...